Omnicell

SEPTEMBER 5, 2022

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

SEPTEMBER 5, 2022

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

SEPTEMBER 5, 2022

Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. Worst yet, 74% of all respondents were aware of at least one pharmacy compounding error in the last 12 months.

Compounding 52

Compounding Sterile Compounds Compounding Pharmacies Documentation 52